Presently, the FDA has not approved a single antiviral drug for COVID-19, and there is an urgent need to develop effective therapeutic strategies that can suppress SARS-CoV-2 infections. Many approaches have been researched, including emerging exosome-based therapies. The interplay between exosomes and viruses could be potentially exploited for antiviral drug and vaccine development. Exosomes...